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Abstract: OBJECTIVE: To assess associations between preserved spinal cord tissue quantified by the
width of ventral and dorsal tissue bridges and neuropathic pain development after spinal cord injury.
METHODS: This retrospective longitudinal study includes 44 patients (35 men; mean (SD) age, 50.05
(18.88) years) with subacute (ie, 1 month) spinal cord injury (25 patients with neuropathic pain, 19
pain-free patients) and neuroimaging data who had a follow-up clinical assessment at 12 months. Widths
of tissue bridges were calculated from midsagittal T2-weighted images and compared across groups. Re-
gression analyses were used to identify relationships between these neuroimaging measures and previously
assessed pain intensity and pin-prick score. RESULTS: Pin-prick score of the 25 patients with neuro-
pathic pain increased from 1 to 12 months (Δmean=10.08, 95% CI 2.66 to 17.50, p=0.010), while it
stayed similar in pain-free patients (Δmean=2.74, 95% CI -7.36 to 12.84, p=0.576). They also had larger
ventral tissue bridges (Δmedian=0.80, 95% CI 0.20 to 1.71, p=0.008) at 1 month when compared with
pain-free patients. Conditional inference tree analysis revealed that ventral tissue bridges’ width (฀2.1
or >2.1 mm) at 1 month is the strongest predictor for 12 months neuropathic pain intensity (1.90±2.26
and 3.83±1.19, p=0.042) and 12 months pin-prick score (63.84±28.26 and 92.67±19.43, p=0.025). IN-
TERPRETATION: Larger width of ventral tissue bridges-a proxy for spinothalamic tract function-at 1
month post-spinal cord injury is associated with the emergence and maintenance of neuropathic pain and
increased pin-prick sensation. Spared ventral tissue bridges could serve as neuroimaging biomarkers of
neuropathic pain and might be used for prediction and monitoring of pain outcomes and stratification of
patients in interventional trials.
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ABSTRACT
Objective To assess associations between preserved 
spinal cord tissue quantified by the width of ventral and 
dorsal tissue bridges and neuropathic pain development 
after spinal cord injury.
Methods This retrospective longitudinal study includes 44 
patients (35 men; mean (SD) age, 50.05 (18.88) years) with 
subacute (ie, 1 month) spinal cord injury (25 patients with 
neuropathic pain, 19 pain- free patients) and neuroimaging 
data who had a follow- up clinical assessment at 12 
months. Widths of tissue bridges were calculated from 
midsagittal T2- weighted images and compared across 
groups. Regression analyses were used to identify 
relationships between these neuroimaging measures and 
previously assessed pain intensity and pin- prick score.
Results Pin- prick score of the 25 patients with 
neuropathic pain increased from 1 to 12 months 
(Δmean=10.08, 95% CI 2.66 to 17.50, p=0.010), while 
it stayed similar in pain- free patients (Δmean=2.74, 
95% CI −7.36 to 12.84, p=0.576). They also had larger 
ventral tissue bridges (Δmedian=0.80, 95% CI 0.20 to 
1.71, p=0.008) at 1 month when compared with pain- free 
patients. Conditional inference tree analysis revealed that 
ventral tissue bridges’ width (≤2.1 or >2.1 mm) at 1 month 
is the strongest predictor for 12 months neuropathic 
pain intensity (1.90±2.26 and 3.83±1.19, p=0.042) and 
12 months pin- prick score (63.84±28.26 and 92.67±19.43, 
p=0.025).
Interpretation Larger width of ventral tissue bridges—a 
proxy for spinothalamic tract function—at 1 month post- 
spinal cord injury is associated with the emergence and 
maintenance of neuropathic pain and increased pin- prick 
sensation. Spared ventral tissue bridges could serve as 
neuroimaging biomarkers of neuropathic pain and might 
be used for prediction and monitoring of pain outcomes 
and stratification of patients in interventional trials.
INTRODUCTION
Spinal cord injury (SCI) is a devastating and life- 
changing event. In most cases, it produces imme-
diate and permanent sensory, motor and autonomic 
dysfunction below the level of injury, resulting in a 
reduced quality of life.1 Along with the functional 
deficits, the majority of patients develops neuro-
pathic pain (NP) at and/or below the level of injury.2 
NP usually arises early after SCI,2 3 is often refractory 
to treatment2 4 5 and normally persists over years3 
with a potentially increasing intensity.6 Although 
the origin of NP is largely unknown, it is thought to 
arise at least partially in the spinal cord.7 8 Preserved 
tissue bridges adjacent to the intramedullary lesion 
cavity, which can be identified in all patients with 
incomplete SCI,9 are permissive for electrophysio-
logical information flow and the size of which is 
predictive of functional recovery.9–11 Importantly, 
NP below the level of injury develops over time.12 
This suggests that fractions of sensory pathways 
within preserved tissue bridges become active over 
time and may affect both ascending and descending 
modulatory systems.13–15 Moreover, hyperactive 
dorsal horn neurons of the spinothalamic tract 
have been identified as a possible pathobiological 
substrate.13 Interestingly, recovery of spinothalamic 
tract function (eg, pin- prick score) is enhanced in 
patients with SCI suffering from NP and its magni-
tude has been associated with pain intensity.16
Based on neuroimaging, the location and width of 
spared midsagittal tissue bridges have been shown 
to be critically involved in the recovery of senso-
rimotor function.9–11 17 For example, dorsal tissue 
bridges covering the dorsal columns are predictive 
of sensory evoked potentials and recovery of light- 
touch function11 and may transmit pain signals 
evoked by normally non- painful stimuli (ie, allo-
dynia).18 19 Ventral tissue bridges have been linked 
to recovery of motor function11 and cover, next to 
the anterior corticospinal tract,20 also portions of 
the anterior spinothalamic tract.21 Thus, the ques-
tion arises whether width of ventral and dorsal 
tissue bridges can predict the emergence and/or 
maintenance of NP after SCI.
This study aimed to explore the value of spared 
midsagittal tissue bridges (ventral and dorsal) 
derived from conventional T2- weighted (T2w) 
serial scans9–11 in predicting the emergence and 
maintenance of SCI- related NP. Therefore, we 
investigated the relationships between the width of 
ventral and dorsal tissue bridges and pain intensity 
as well as its clinical characteristics.
METHODS
Experimental design
In this retrospective study, we included 44 patients 
with subacute SCI (28 tetraplegic and 16 paraplegic 
patients) who were admitted consecutively to the 
Balgrist University Hospital (Zurich, Switzerland) 
between May 1996 and January 2019. Of these 44 
patients, all had a follow- up clinical assessment and 
32 had a neuroimaging follow- up visit at 12 months 
post- SCI (figure 1).
We used 1 month and 12 months neuroimaging, 
neuropathic pain and clinical data from these 
patients to investigate group differences and clin-
icopathological relationships as well as outcome 
predictions by means of regression analysis and 
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of interest included were lesion parameters as well as pain and 
clinical outcome measures at 1 month and 12 months follow- up.
We excluded patients with pre- existing neurological or 
mental disorders or brain lesions, as well as patients with MRI 
contraindications.
Tissue bridge data from a small subset of the study population 
was previously reported in a different context.9–11
Clinical assessments
All patients were clinically examined using a comprehensive 
clinical protocol including 1) the International Standards for 
Neurological Classification of Spinal Cord Injury protocol22 and 
2) the European Multicenter Study about Spinal Cord Injury 
(EMSCI) pain questionnaire (V.4.2, http://www. emsci. org/). On 
the EMSCI questionnaire, patients rate various aspects of pain 
(eg, current pain intensity, mean and maximal pain intensity 
during the last week before the assessment, location and quality 
of pain, intensity of allodynia and paraesthesia). The pain inten-
sity was quantified using an 11- point numeric rating scale with 
‘0’ indicating no pain and ‘10’ indicating the worst imaginable 
pain. Data from the EMSCI pain questionnaire was available for 
43 patients with SCI at 1 month (24 patients with NP, 19 pain- 
free patients) and 42 patients at 12 months post- SCI (28 patients 
with NP, 14 pain- free patients). One patient and two patients 
without EMSCI pain questionnaire at 1 month and 12 months, 
respectively, reported to suffer from NP.
Image acquisition
All study participants underwent MRI on 1.5 or 3 T Philips 
(Philips Healthcare, Best, The Netherlands), Siemens (Siemens 
Healthcare, Erlangen, Germany) or GE (GE Medical Systems, 
Waukesha, Wisconsin, USA) scanners. A 32- channel receive 
spine coil integrated in the table was used with all scanners. 
The anatomical MRI protocol consisted of standard sagittal 
T1- weighted, sagittal T2w and axial T2w clinical scans obtained 
at the lesion level. Repetition time (TR), echo time (TE) and flip 
angle (FA) of the sagittal T2w clinical sequences were used as 
follows: at 1.5 T (TR=4138 ms; TE=109 ms; FA=149 degrees) 
and at 3 T (TR=3938 ms; TE=97 ms; FA=153 degrees). The 
echo train length was 19 at 1.5 T and 17 at 3 T. At 1.5 and 
3 T, the field of view9 was set to 330 mm×330 mm and 220 
mm×220 mm, respectively. To reduce metal artefacts, readout 
bandwidths were increased at 1.5 T (415 Hz/pixel) and at 3 T 
(751 Hz/pixel). The spatial resolution of sagittal T2w images 
was 0.55 mm×0.55 mm×2.75 mm at 1.5 T and 0.57 mm×0.57 
mm×2.75 mm at 3 T. The midsagittal slices of sagittal T2w scans 
were the ones used for lesion segmentation analysis.9–11
Image analysis
Together with oedema and haemorrhage, intramedullary damage 
manifests as changes of signal intensity on T2w scans.23 Crucially, 
hyperintense signal changes in the subacute phase reliably reflect 
neural damage within the spinal cord9 10 rather than oedema and 
haemorrhage which is harder to differentiate in the acute phase 
after SCI. Patients’ neuroimaging data were only included if T2w 
scans showed a clearly visible lesion (ie, hyperintense signal)—if 
present—on the midsagittal slice whereas scans with insufficient 
image quality or lesion visibility due to metal artefacts were 
excluded.9–11 Neuroimaging data with appropriate image quality 
and lesion visibility was available for 44 patients with subacute 
SCI of which 32 had a follow- up scan at 12 months post- SCI.
Lesion segmentation was performed manually and blinded to 
patient identity and scan time point by rater DP. We used the 
Jim software (V.7.0, Xinapse Systems, Aldwincle, UK) to delin-
eate the lesion on the midsagittal slice from sagittal T2w scans. 
This enabled us to assess the lesion area, its rostro- caudal lesion 
length, anterior- posterior lesion width and ventral and dorsal 
tissue bridges, the sum of both reflecting the total width of tissue 
bridges (ie, hypointense regions between the relatively hyperin-
tense adjacent cystic cavity within the spinal cord and the cere-
brospinal fluid).9 10
Statistical analysis
Statistical analysis was performed using Stata software (V.4.2; 
StataCorp, College Station, Texas, USA). We used unpaired two- 
tailed t- tests to compare patients with SCI with NP and pain- free 
patients with SCI regarding their age at 1 month scanning time 
point and the time interval between injury and 1 month scan. 
Paired two- tailed t- tests were used for comparison of midsagittal 
tissue bridges (ie, total, ventral and dorsal), pin- prick score and 
mean pain intensity at 1 month and 12 months post- SCI.
We applied Mann- Whitney U tests for pairwise comparisons 
of patient groups regarding their pin- prick score and width 
of midsagittal tissue bridges (ie, ventral, dorsal and total) at 
1 month and 12 months post- SCI as well as rate of change in pin- 
prick score from 1 month to 12 months.
We used multivariable linear regression analysis to investigate 
associations between imaging measures (ie, width of ventral 
midsagittal tissue bridges) and mean pain intensity at 1 month. 
One month quantitative lesion measures were also used with the 
same model to predict mean NP intensity and recovery of pain 
sensation (ie, pin- prick score) at 12 months follow- up. Age and 
sex were included as covariates of no interest in the regression 
models to adjust for linear age and sex dependency. Models 
including ventral tissue bridges were also corrected for dorsal 
Figure 1 Study population with participant numbers, neuroimaging 
and pain characteristics as well as follow- up rate. Illustrative flow diagram 
showing the sample size of the study with subgroups according to their 
presence or absence of neuropathic pain (NP) and tissue bridges (TB). From 
44 patients with subacute spinal cord injury (SCI), all had a follow- up pain 
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tissue bridges. Prediction models were furthermore adjusted for 
1 month clinical scores (eg, pin- prick score at 1 month). Potential 
confounders were only retained if the covariates were significant 
or if they had a substantial effect on the correlation coefficient of 
interest. Results were regarded as significant when the p values 
were ≤0.05 and CIs were set to 95%.
We further used a widely used24–28 unbiased recursive parti-
tioning technique called conditional inference tree (URP- 
CTREE)29 implemented in the ‘party’ package within R30 
(V.3.4.3). URP- CTREE performs a prospective prediction- based 
stratification of a patient population with regard to predefined 
outcome variables. URP- CTREE is a tree- structured regres-
sion model for independence tests between sets of predictors 
(eg, early imaging parameters) and specified future clinical end 
points (eg, pain sensation measures). We used 1 month ventral 
and dorsal midsagittal tissue bridges’ widths as predictors for 
mean neuropahtic pain intensity and pin- prick score at 1 month 
and 12 months. The URP- CTREE algorithm dichotomously 
separates an initial heterogeneous patient population into more 
homogeneous and well- defined pairs of subgroups (ie, nodes) 
with respect to the future clinical outcomes specified. Subgroups 
that will be further separated are referred to as inner nodes. 
Separation goes on as long as one of the predictor variables is 
found to be associated with the predefined clinical end point 
and to split the group into two disjoint subgroups with a p value 
≤0.05. The algorithm is designed in a way that every separation 
is based on the singular most significant predictor with the aim to 
maximise the difference between the newly formed subgroups. 
Splitting groups is continued as long as there is any significant 
predictor value.
Data availability
Anonymised data of this study are available on request from the 
corresponding author.
RESULTS
Demographics and clinical characteristics
Forty- four patients with SCI (n=35 men (79.5%)) with a 
mean (±SD) age of 50.05±18.88 years were included. Patients 
with NP (50.40±17.38 years, n=25) and pain- free patients 
(49.58±21.17 years, n=19) did not differ in their age at 
1 month (Δmean=−0.82, 95% CI −12.55 to 10.91, p=0.888). 
The patients’ time interval between injury and 1 month scan (ie, 
subacute stage) was 32.95±16.85 days. There was no difference 
in time since injury (Δmean=4.80, 95% CI −5.56 to 15.17, 
p=0.355) between patients with NP (30.88±17.55 days, n=25) 
and pain- free patients (35.68±15.93 days, n=19).
Over time, NP developed in six initially pain- free patients 
whereas one patient with NP at baseline reported to be 
NP- free at follow- up. Patients with NP at 1 month (56.8%) and 
12 months follow- up (68.2%) reported a similar mean NP inten-
sity of 3.67±1.61 and 3.68±1.61 (Δmean=0.01, 95% CI −0.89 
to 0.91, p=0.979), respectively. Pin- prick score of patients with 
SCI with NP was 70.08±28.40 at 1 month and increased to 
80.16±27.88 at 12 months post- SCI (Δmean=10.08, 95% CI 
2.66 to 17.50, p=0.010, n=25). In pain- free patients, 1 month 
pin- prick score was 57.84±25.02 and did not significantly 
change over time (60.58±27.25 at follow- up (Δmean=2.74, 
95% CI −7.36 to 12.84, p=0.576, n=19)). Between both 
patient groups, there was no difference in pin- prick score at 
1 month (Δmedian=15.00, 95% CI −7.00 to 29.00, p=0.184) 
and the rate of change in pin- prick score from 1 month to 
follow- up at 12 months did not differ (Δmedian=3.00, 95% CI 
−3.00 to 12.00, p=0.286).
The role of midsagittal tissue bridges in NP
Of 44 patients, 8 (ie, American Spinal Injury Association Impair-
ment Scale (AIS) A patients) had no midsagittal tissue bridges 
(18.2%) while the remaining 36 (ie, 1 AIS A and 35 AIS B–D 
patients) did have midsagittal tissue bridges (81.8%) with an 
average width of 2.21±1.65 mm. Thirty- one of 44 (70.5%) 
patients had ventral tissue bridges with an average width of 
1.17±1.18 mm and 29 of 44 (65.9%) had dorsal tissue bridges 
with an average width of 1.03±1.20 mm. Twenty- four patients 
had both ventral and dorsal tissue bridges while seven and five 
patients had only ventral or dorsal bridges, respectively.
At 1 month, width of total midsagittal tissue bridges was 
larger (Δmedian=1.15, 95% CI 0.00 to 2.12, p=0.034, 
figure 2A) in patients with SCI with NP (2.67±1.71 mm, 
n=25) when compared with pain- free patients (1.60±1.38 mm, 
n=19). At 1 month, ventral tissue bridges of patients with NP 
(1.60±1.25 mm, n=25) were larger (Δmedian=0.80, 95% CI 
0.20 to 1.71, p=0.008) in comparison to pain- free patients 
(0.61±0.81 mm, n=19). Dorsal tissue bridges at 1 month were 
similar (Δmedian=0.00, 95% CI −0.69 to 0.50, p=0.790) in 
patients with NP (1.07±1.33 mm, n=25) and pain- free patients 
(0.99±1.03 mm, n=19).
Of 25 patients with SCI with NP and 19 pain- free patients, 
17 and 15 had imaging follow- up data, respectively (table 1). In 
the 17 patients with NP, width of total tissue bridges was similar 
at 1 month and 12 months post- SCI (Δmean=0.29 mm, 95% CI 
−0.12 to 0.69 mm, p=0.153, figure 2B). Within the pain- free 
group, width of total tissue bridges was also comparable between 
1 month and 12 months follow- up (Δmean=−0.48 mm, 95% CI 
−1.02 to 0.07 mm, p=0.081). Width of ventral tissue bridges 
was comparable at 1 month and 12 months in patients with NP 
(Δmean=−0.04 mm, 95% CI −0.39 to 0.31 mm, p=0.816, 
figure 2C) and pain- free patients (Δmean=−0.33 mm, 95% CI 
−0.73 to 0.07 mm, p=0.097). Similarly, the rate of change in 
width of dorsal tissue bridges over time was similar for patients 
with NP (Δmean=0.32 mm, 95% CI 0.00 to 0.65 mm, p=0.053, 
figure 2D) and pain- free patients (Δmean=−0.15 mm, 95% CI 
−0.43 to 0.13 mm, p=0.280).
Association of tissue bridges and clinical pain measures at 1 
month
Larger width of ventral tissue bridges at 1 month was associated 
with a higher mean pain intensity at 1 month (coefficient=0.23, 
95% CI 0.07 to 0.39, p=0.005, R2=0.179, n=43, figure 3A), 
adjusted for dorsal tissue bridges and age.
URP- CTREE analysis led to a partition of the entire cohort 
(p=0.013, n=43, figure 3B) into two terminal nodes with 
regard to the patients’ mean pain intensities (ranging from 0 to 
10) at 1 month, according to the 1 month width of ventral tissue 
bridges being ≤2.1 mm (n=31, node 2) or >2.1 mm (n=12, 
node 3). The two subgroups presented 1 month mean NP inten-
sities of 1.45±2.05 and 3.58±1.83, respectively.
Association of tissue bridges and clinical pain measures at 12 
months
Larger ventral tissue bridges at 1 month were associated with a 
higher mean NP intensity (coefficient=0.20, 95% CI 0.03 to 
0.36, p=0.022, R2=0.131, n=42) and higher pin- prick score at 
12 months (coefficient=0.03, 95% CI 0.01 to 0.04, p<0.001, 
R2=0.355, n=44), independent of dorsal tissue bridges, age and 
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patients with NP (coefficient=0.03, 95% CI 0.01 to 0.04, 
p=0.007, R2=0.385, n=30, figure 4A), but not pain- free 
patients (coefficient=−0.01, 95% CI −0.03 to 0.02, p=0.525, 
R2=−0.386, n=14) showed a positive relationship between 
width of ventral tissue bridges at 1 month and pin- prick score 
at 12 months.
URP- CTREE analysis separated the entire cohort (p=0.042, 
n=42) into two terminal nodes with regard to the patients’ mean 
pain intensities at 12 months, according to the 1 month width of 
ventral tissue bridges being ≤2.1 mm (n=30, node 2) or >2.1 mm 
(n=12, node 3). The two subgroups presented 12 months mean 
pain intensities of 1.90±2.26 and 3.83±1.19, respectively. The 
URP- CTREE algorithm also identified 1 month ventral tissue 
bridges as a predictor for 12 months pin- prick score, its width 
separating the initial group (p=0.025, n=44, figure 4B) into two 
nodes with ≤2.1 mm (n=32, node 2) and >2.1 mm (n=12, node 
5) in ventral tissue bridges’ width. The two subgroups presented 
12 months pin- prick scores of 63.84±28.26 and 92.67±19.43, 
respectively. In a second step, the algorithm identified width of 
dorsal tissue bridges as a second predictor variable (p=0.030) for 
the subgroup showing a width of ventral tissue bridges ≤2.1 mm 
and separated it into two more nodes with ≤1.62 mm (n=24, 
node 3) and >1.62 mm (n=8, node 4) in dorsal tissue bridges’ 
width. The two subgroups presented 12 months pin- prick scores 
of 56.58±27.18 and 85.63±19.66, respectively.
DISCUSSION
This study demonstrates the potential involvement of spared 
ventral tissue bridges in the development and maintenance of 
NP following SCI. In particular, patients with NP had larger 
total and ventral tissue bridges when compared with pain- free 
patients, their width at 1 month being a predictor for a higher 
NP intensity and higher pin- prick score at 12 months post- SCI.
As expected,2 31 about two- third (68.2%) of the patients with 
SCI enrolled in this study developed NP of which more than 
half had already NP at the subacute stage (56.8%). Hari et al16 
reported that enhanced recovery of spinothalamic tract function 
(ie, pin- prick) is associated with NP after SCI, and Hatem et al32 
showed that there were less spinothalamic tract impairments in 
patients with syringomyelia with both spontaneous and evoked 
pain when compared with patients with spontaneous pain only. 
In our study, recovery of pin- prick score (ie, clinical measure for 
Figure 2 Between and within group comparison of tissue bridges at 1 month and 12 months. (A) Group differences of total, ventral and dorsal tissue 
bridges are shown for patients with spinal cord injury with neuropathic pain (NP) (indicated in red) and pain- free patients (indicated in blue). (B–D) 
Spatiotemporal evolutions of (B) ventral, (C) dorsal and (D) total tissue bridges from 1 month to 12 months are shown for patients with spinal cord injury 
with NP (indicated in red) and pain- free patients (indicated in blue) separately. Uncorrected p values are reported for significant differences.
Table 1 Dynamic change of width of total, ventral and dorsal tissue bridges
Patients with SCI with NP (n=17) Pain- free patients with SCI (n=15)
Width of tissue bridges 1 month 12 months 1 month 12 months
Total, mean (SD), mm 2.45 (1.64) 2.73 (1.48) 1.60 (1.33) 1.12 (1.17)
Ventral, mean (SD), mm 1.46 (1.29) 1.42 (0.94) 0.75 (0.86) 0.42 (0.68)
Dorsal, mean (SD), mm 0.99 (1.20) 1.31 (1.29) 0.85 (0.74) 0.70 (0.66)



























































































































5Pfyffer D, et al. J Neurol Neurosurg Psychiatry 2020;0:1–7. doi:10.1136/jnnp-2020-323150
Spinal cord injury
pain sensation) paralleled the emergence of NP and its intensity 
while no substantial change was observed in the pain- free group. 
This supports the notion that recovery of spinothalamic function 
is involved in the emergence and/or maintenance of NP.8 16 32–34
Ventral tissue bridge measures are likely to cover the anterior 
spinothalamic tract.21 Interestingly, patients with NP had greater 
width of ventral tissue bridges at baseline and follow- up, while 
the width of dorsal tissue bridges was similar between groups 
at both time points. Crucially, larger ventral tissue bridges at 
1 month are associated with higher mean pain intensities at 1 
Figure 4 Regression analyses between width of tissue bridges at 1 
month and pin- prick score at 12 months. (A) Regression graph showing 
the association of pin- prick score at 12 months with width of ventral 
tissue bridges at 1 month for patients with spinal cord injury with 
neuropathic pain (NP) (indicated in red) and pain- free patients (indicated 
in blue). The red and blue lines indicate the corresponding linear fits. (B) 
Unbiased recursive partitioning conditional inference tree for the clinical 
end point pin- prick score at 12 months of all patients with spinal cord 
injury (n=44). Ventral and dorsal tissue bridges’ widths at 1 month were 
used as predictors in the model. The algorithm led to a partition of the 
initial patient population (node 1) into one more inner node (node 2) 
and finally into three terminal nodes (nodes 3, 4 and 5) representing the 
more homogeneous subgroups. Box plots at the bottom show sizes of the 
subgroups, indicated above each terminal node, with their corresponding 
distributions (including two- sided error bars) of the clinical end point. 
Uncorrected p values are reported in (A) and multiple testing- corrected (ie, 
Bonferroni- corrected) p values are reported in (B) for significant differences.
Figure 3 Regression analyses between width of tissue bridges and mean 
pain intensity at 1 month. (A) Regression graph showing the association 
of mean pain intensity at 1 month with width of ventral tissue bridges 
at 1 month for all patients with spinal cord injury. The red line indicates 
the linear fit. (B) Unbiased recursive partitioning conditional inference 
tree for the clinical end point mean pain intensity at 1 month of patients 
with spinal cord injury with available pain intensity data at 1 month 
(n=43). Ventral and dorsal tissue bridges’ widths at 1 month were used 
as predictors in the model. The algorithm led to a partition of the initial 
patient population (node 1) into two terminal nodes (nodes 2 and 3) 
representing the more homogeneous subgroups. Box plots at the bottom 
show sizes of the subgroups, indicated above each terminal node, with 
their corresponding distributions (including two- sided error bars) of the 
clinical end point. Uncorrected p values are reported in (A) and multiple 




























































































































6 Pfyffer D, et al. J Neurol Neurosurg Psychiatry 2020;0:1–7. doi:10.1136/jnnp-2020-323150
Spinal cord injury
month and 12 months, independent of dorsal tissue bridges. By 
means of URP- CTREE analysis, we further identified ventral 
tissue bridges at 1 month as predictors of recovery of pin- prick 
scores at 12 months with a cut- off value of 2.1 mm. Next to the 
implication of ventral tissue bridges, dorsal tissue bridges might 
also be involved in the generation of NP.18 19 To examine pin- prick 
sensation (ie, clinical pain measure), the patient needs to distin-
guish a sharp and a dull end of a pin when blindfolded.22 Thus, 
next to spinothalamic tract function, the medial lemiscal system 
running through the dorsal columns (ie, dorsal tissue bridges) is 
also involved as it conveys the information for tactile discrimi-
nation.35 Thus, dorsal tissue bridges likely involve second- order 
neurons of the spinothalamic tract within the substantia gelati-
nosa of the spinal cord dorsal horn.36 Sparing of these neurons 
could be of high importance for maintenance or recovery of 
clinical pain sensation (ie, pin- prick score) at dermatomes corre-
sponding to the lesioned spinal cord levels. Finnerup et al37 
reported that patients with SCI with NP, when compared with 
pain- free patients with SCI, showed more sensory hypersensi-
tivity in lesion level- related dermatomes, suggesting a key role 
of sensory neuronal hyperexcitability in NP following SCI.38–40
This study has limitations. First of all, this study is a retro-
spective monocentric study with specified inclusion criteria. 
This likely represents a bias source as the study design resulted 
in a homogeneous data set, but might not reflect the general 
SCI population. Future studies would therefore benefit from a 
prospective multicentric design including larger patient numbers. 
Furthermore, women and men were not equally distributed in 
our patient cohort. However, this is also not the case for the 
general SCI population.41 Quantification of tissue bridges was 
only performed on midsagittal but not parasagittal slices. Further 
quantification of lateral tissue bridges on T2w axial slices was 
also not possible due to a low spatial resolution. This limits 
information about specific spared tracts and potential correla-
tions with their corresponding functions. These points should be 
addressed in future studies to further explore the already prom-
ising method of tissue bridges characterisation9–11 17 with its reli-
able quantification already at early stages after SCI and even in 
the presence of metal artefacts near the lesion.10 The EMSCI pain 
questionnaire rather crudely assesses NP characteristics. Future 
studies would benefit from using more detailed pain assessments 
including drawings of the body with the extent, quality and 
intensity of the perceived pain at different body parts.42 Finally, 
even though our sample size was rather large, including more 
patients in the URP- CTREE analysis would increase the chances 
of reliably predicting future clinical end points and stratifying a 
heterogeneous patient cohort into homogeneous subgroups via 
multilevel inference trees and corresponding predictor variables.
This study identifies spared tissue bridges as quantifiable 
neuroimaging biomarkers assessed by conventional MRI 
predicting the emergence and maintenance of NP. Specifi-
cally, we identified 1 month width of ventral tissue bridges as 
the strongest predictor of NP intensity and pin- prick score at 
12 months post- SCI. Thus, ventral tissue bridges represent MRI 
metrics, which could be readily implemented in the daily clinical 
routine to serve as promising, reliable and time- saving neuroim-
aging biomarkers for the monitoring of NP and for stratification 
of patient subgroups in interventional clinical trials.
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